- Home
- NXE vs BRKR Comparison
NXE vs BRKR Comparison
Compare NXE & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NXE | BRKR |
|---|---|---|
| Founded | 2011 | 1960 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.7B |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | NXE | BRKR |
|---|---|---|
| Price | $10.28 | $56.39 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $48.54 |
| AVG Volume (30 Days) | ★ 6.1M | 2.7M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | N/A | $6.30 |
| Revenue Next Year | $75.07 | $3.81 |
| P/E Ratio | ★ N/A | $2,998.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.26 | $28.53 |
| 52 Week High | $13.96 | $64.54 |
Technical Indicators
Market Signals| Indicator | NXE | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 39.05 | 65.43 |
| Support Level | $7.79 | $46.84 |
| Resistance Level | $13.26 | N/A |
| Average True Range (ATR) | 0.55 | 3.04 |
| MACD | -0.01 | 1.06 |
| Stochastic Oscillator | 0.00 | 64.99 |
Price Performance
Historical ComparisonAbout NXE Nexgen Energy Ltd.
NexGen Energy Ltd is an exploration and development stage entity engaged in the acquisition, exploration, evaluation, and development of uranium properties in Canada. The Rook I Project is a development-stage uranium project in Canada. The Company also holds a prospective portfolio of uranium exploration projects in the historic eastern Athabasca Basin.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.